Literature

Extraction of a comprehensive steroid panel from human serum using Biotage® Mikro ABN

Written by Biotage | Dec 6, 2025 3:15:00 AM

For research use only. NOT for use in diagnostic procedures.

Figure 1. Structures of DHEAS, Estradiol and Testosterone.

Introduction

This application note describes the extraction of steroid hormones from human serum using Biotage® Mikro ABN microelution plates prior to LC/MS-MS analysis. The simple sample preparation procedure delivers clean extracts and analyte recoveries mostly greater than 70% with RSDs lower than 5% for most analytes. Linearity of greater than 0.99 is achieved for all analytes from 1–1000 pg/mL. An elution volume of 30 µL is used, which is simply diluted prior to analysis, avoiding a time consuming evaporation step.

Mikro plate extraction allows for very low elution volumes and enhanced workflow efficiency.

Analytes

Cortisol, 18-OH-Corticosterone, 21-Deoxycortisol, Cortisone, Estradiol, 17-OH-Pregnenolone, Aldosterone, 11-Deoxycortisol, Corticosterone, Estrone, Dehydroepiandrosterone (DHEA), 17- OH-Progesterone, Dehydroepiandrosterone sulfate (DHEA-S), Testosterone, Dihydrotestosterone (DHT), Pregnenolone, Androstenedione, 11-deoxycorticosterone, Progesterone

Internal standards

Dihydrotestosterone- D3 (DHT-D3) and Aldosterone-D4.

Sample preparation procedure

Format

Biotage® Mikro ABN Plate, 2 mg, part number 600-0002-LVP

Sample pre-treatment

Spike serum (200 µL) with internal standard solution and allow to equilibrate for 1 hour. Dilute with 1% formic acid (1:1, v/v). Mix.

Internal standard solution consisted of 10 pg/µL methanolic solution. 20 µL was added to 200 µL serum to give a 1 ng/mL spike concentration.

Conditioning

Condition wells with methanol (100 µL)

Equilibration

Equilibrate wells with 0.1% formic acid (100 µL)

Sample loading

Load 400 µL of the pre-treated serum sample

Wash 1

Elute interferences with water (100 µL)

Wash 2

Elute interferences with H2O:MeOH (60:40, v/v, 100 µL)

Dry

Dry plate for 2 minutes

Elution

Elute analytes with methanol (30 µL)

Collection vessels

Collect the eluent in a 1 mL square well collection plate (p/n 121-5202).

Post elution: Dilute

Add a aliquot of water (30 µL) to each well. Vortex mix and cover plate with a sealing mat prior to injection.

Processing conditions

Biotage® Mikro plates were processed using a Biotage® Pressure+ Positive Pressure Manifold.

Settings:

  • Condition, equilibrate, load, wash and elute steps: 7–9 psi (fine control setting)
  • Plate dry step: 40 psi coarse setting for 2 minutes

UHPLC conditions

Instrument

Shimadzu Nexera x2 UHPLC

Column

ACE C18 (100 mm x 2.1 mm, 1.7 µm) with a Restek EXP holder and ARC-18 guard

Mobile phase

A: 0.2 mM Ammonium Fluoride (aq)
B: Methanol

Flow rate

0.4 mL/min

Column temperature

40 oC

Injection volume

5 µL

Table 1. HPLC gradient.

Time (min.)

%A

%B

0

50

50

2

50

50

5

40

60

8

10

90

9

5

95

9.1

5

95

9.2

50

50

MS conditions

Instrument

Shimadzu 8060 Triple Quadrupole MS using ES interface

Nebulizing gas flow

3 L/min

Drying gas flow

3 L/min

Heating gas flow

17L/min

Interface temperature

400 °C

DL temperature

250 °C

Heat block temperature

400 °C

CID gas flow

270 kPa


Table 2. MS conditions and retention times for target analytes in positive
and negative mode.

Analytes

MRM Transition

Collision Energy

Ion Mode

DHEAS

367.1 > 97.05

33

-

(367.1 > 191.05)

Cortisol

363.4 > 121.25

-24

+

(363.40 > 327.15)

18-OH-Corticosterone

363.3 > 269.2

-16

+

(363.30 > 121.10)

Cortisone

361.3 > 163.15

-22

+

(361.30 > 329.15)

21-Deoxycortisol

347.1 > 311.2

-16

+

(347.10 > 269.20)

Estradiol

271.1 > 145.2

39

-

(271.10 > 183.25)

Aldosterone-D4

363.1 > 190.3

19

-

 

359.1 > 189.25

   

Aldosterone

(359.00 > 297.15)

18

-

17-OH-Pregnenolone

315.3 > 297.2

-13

+

(315.30 > 251.00)

 

347.3 > 109.25

   

11-Deoxycortisol

(347.30 > 283.15)

-27

+

Corticosterone

347.3 > 329.25

-16

+

(347.30 > 283.15)

Estrone

269.2 > 145.2

37

-

(269.20 > 143.20)

11-Deoxycorticosterone

331.3 > 109.05

-25

+

(331.30 >97.25)

 

271.10 > 253.20

   

DHEA

(271.10 >213.20)

-13

+

Testosterone

289.3 > 97.05

-23

+

(289.3 > 109.2)

-25

DHT-D3

294.4 > 258.25

-16

+

DHT

291.3 > 255.25

-15

+

(291.3 > 199.05)

-15

Androstenedione

287.3 > 97.2

-21

+

(287.30 >109.20)

Pregnenolone

299.3 > 159.25

-20

+

(299.30 > 281.20)

17-OH-Progesterone

331.3 > 97.1

-22

+

Progesterone

315.2 > 97.2

-22

+

(331.30 > 109.15)

Results

Recovery data for the steroid panel is shown in figure 2. Typical analyte recoveries above 70%, with corresponding RSDs below 10% were achieved.


Note that for recovery of the polar DHEAS metabolite, methanol is used the elution solvent. This has the added advantage that it can be diluted with water and injected directly into the LC-MS/MS system, eliminating the need for time consuming evaporation steps. Direct injection of the elution solvent is also possible, but some peak broadening of early eluting analytes was observed, reducing the sensi- tivity for these analytes.


Figure 3. demonstrates representative chromatography obtained from stripped serum spiked at 5 ng/mL. Satisfactory resolution of the various isobars was obtained using the ACE C18 UPLC cartridge. In order to achieve low level detection of analytes in positive and negative ion modes a combination of 0.2 mM NH4F (aq) and MeOH was utilized.

Calibration curve performance was investigated from stripped serum spiked in the range 1–1000 pg/mL. Good linearity was observed for all analytes typically delivering r2 values greater than 0.99. Table 3. details linearity performance and associated LOQ for each analyte. Example calibration curves are shown in Figure 4.


Figure 2. Typical analyte % extraction recoveries (n=7) using the extraction procedure
described in this application note.

Table 3. Analyte calibration curve r2 and LOQ performance.

Analyte

r2

LLOQ (pg/mL) Dilute

DHEAS

0.9990

50

Cortisol

0.9991

50

18-OH-Corticosterone

0.9991

50

Cortisone

0.9997

25

21-Deoxycortisol

0.9998

100

Estradiol

0.9995

50

Aldosterone

0.9995

50

11-Deoxycortisol

0.9991

25

Corticosterone

0.9995

250

Estrone

0.9991

25

11-Deoxycorticosterone

0.9992

50

DHEA

0.9994

250

Testosterone

0.9992

5

DHT

0.9991

100

Androstenedione

0.9995

10

Pregnenolone

0.9997

500

17-OH-Progesterone

0.9997

100

Progesterone

0.9997

1

Figure 3. Representative chromatography for stripped serum spiked at 5 ng/mL.
Figure 4. Calibration curves for Estradiol (a), Testosterone (b), 17-OH-Progesterone (c) and Androstenedione (d) for extracts diluted 1:1 (v/v) prior to analysis.

Chemicals and reagents

  • Methanol (LC-MS grade), Ultra-Pure Methanol (Gradient MS) and formic acid (98%) were purchased from Honeywell Research Chemicals (Bucharest, Romania).
  • All analyte standards and deuterated internal standards were purchased from Sigma- Aldrich Company Ltd. (Gillingham, UK).
  • Water used was 18.2 MOhm-cm, drawn daily from a Direct-Q5 water purifier.
  • Mobile phase A (0.2 mM ammonium fluoride (aq)) was prepared by adding 7.4 mg of ammonium fluoride to 1 L with purified water.
  • Internal standards (100 pg/µL) were prepared from a 10 ng/µL stock solution by adding 10 µL of each of to 950 µL of MeOH. 20 µL of this solution was then added to each calibration sample.
  • The pre-treatment solvent 1% formic acid was made by adding 1 mL of formic acid to 99 mL of water (18.2 MOhm-cm).
  • The equilibration solvent 0.1% formic acid was made by adding 100 µL of formic acid to 99.9mL of water (18.2 MOhm-cm).
  • Wash 2 solution H2O:MeOH (60:40, v/v) was made up by measuring out 60 mL of water (18.2 MOhm-cm) and 40 mL of methanol and adding both to a beaker.

Additional information

  • All data shown in this application note was generated using serum both stripped and unstripped purchased from Golden West.
  • The use of ammonium fluoride in the mobile phase increased sensitivity in both positive and negative ion modes.
  • Increasing sensitivity:
    • For later eluting analytes direct injection of the methanol elution solvent, without dilution is possible.
  • Steroids exhibit non-specific binding to plastic collection plates. Different plastics exhibit different binding characteristics. The use of 2 µL of ethylene glycol can help this issue. This application did not require the use of glycol.

Ordering information

Part Number

Description

Quantity

600-0002-LVP

Biotage® Mikro ABN Plate, 2 mg

1

PPM-96 

Biotage® PRESSURE+ 96 Positive Pressure Manifold

1

121-5202

Collection Plate, 1 mL Square

50

121-5204

Pierceable Sealing Mat

50

 

Literature Number: AN939